MKC-1 | m-entrepreneurship.com

Product Name :
MKC-1

Search keywords :
MKC-1

drugId :
null

Target Vo:
Mammalian target of Rapamycin (mTORC1)

Target Vo Short Name :
mTORC1

Moa_Name:
mTOR Complex 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AKT1/AKT2/AKT3 Antibody (YA635)
BRAF Antibody
CXCL9 Antibody: CXCL9 Antibody is an unconjugated, approximately 14 kDa, rabbit-derived, anti-CXCL9 polyclonal antibody. CXCL9 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, pig, cow, horse background without labeling.

Author: Betaine hydrochloride

Related Posts